This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • lung Cancer
  • /
  • Treatment of dyspnoea in advanced cancer patients:...
Guideline

Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines

Read time: 1 mins
Last updated:31st Aug 2015

Dyspnoea is described as difficult or laboured breathing and is a frequent symptom in advanced cancer patients, with the highest prevalence in lung cancer. Dyspnoea has been demonstrated to be one of the most distressing cancer symptoms and requires a multidisciplinary approach in patient management and care. The new ESMO Clinical Practice Guidelines on the treatment of dyspnoea in advanced cancer patients focus on dyspnoea management strategies including treating reversible causes, non-pharmacological interventions and pharmacological treatment such as opioids, benzodiazepines and other drugs.

 

Read full guideline